Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Friday, Sept. 20, 2013, 98 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $117.60 to $300,598,732.04. Highlighted Stocks Traded by Insiders: Tenet Healthcare (THC) - FREE Research Report Bush John Ellis who is Director at Tenet Healthcare sold 8,291 shares at $42.90 on Sept. 20, 2013. Following this transaction, the Director owned 36,913 shares meaning that the stake was reduced by 18.34% with the 8,291 share transaction. The shares most recently traded at $40.98, down $1.92, or 4.69% since the insider transaction. The average volume for Tenet Healthcare has been 1.6 million shares per day over the past 30 days. Tenet Healthcare has a market cap of $4.3 billion and is part of the health care sector and health services industry. Shares are up 31.72% year to date as of the close of trading on Friday. Tenet Healthcare Corporation, an investor-owned health care services company, owns and operates acute care hospitals, ambulatory surgery centers, diagnostic imaging centers, urgent care centers, and related health care facilities in the United States. Currently there are 7 analysts that rate Tenet Healthcare a buy, no analysts rate it a sell, and 5 rate it a hold. Exclusive Offer: Get the latest Stock Analysis on THC - FREETheStreet Quant Ratings rates Tenet Healthcare as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity. Get the full Tenet Healthcare Ratings Report from TheStreet Quant Ratings now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Wall Street is contemplating what's next for the Republican healthcare effort after nonpartisan analysts found it would leave millions more Americans uninsured and a growing number of lawmakers are balking.